JSPR Earnings

Quarterly EPS
$-1.24
Q3 2024
$-1.62
Q4 2024
$-1.41
Q1 2025
$-1.74
Q2 2025
$-1.13
Q3 2025
$-0.31
Q4 2025
$-0.04
Q1 2026
$-0.10
Q2 2026
Latest RevenueN/A
Latest Net Income-2760000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.100-2760000+94.3%
Q1 2026-$0.040-1174000+97.2%
Q4 2025-$0.310-9101000+80.9%
Q3 2025-$1.130-18736000+8.9%
Q2 2025-$1.740-26723000-79.4%
Q1 2025-$1.410-21241000-36.9%
Q4 2024-$1.620-24321000-8.0%
Q3 2024-$1.240-18637000+22.5%
Q2 2024-$0.970-14583000
Q1 2024-$1.030-13728000
Q4 2023-$1.500-16581000
Q3 2023-$1.600-17544000
Jasper Therapeutics (JSPR) — Earnings